U.S., April 24 -- ClinicalTrials.gov registry received information related to the study (NCT06939777) titled 'Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SNA02-48 Injection in Chinese Adult Participants' on April 15.
Brief Summary: To evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of the full human anti-tetanus toxin monoclonal antibody SNA02-48 injection and compare the Tetanus-antibody levels and safety of SNA02-48 with human tetanus immunoglobulin (HTIG) in Chinese adult participants.
Study Start Date: April, 2025
Study Type: INTERVENTIONAL
Condition:
Tetanus
Intervention:
BIOLOGICAL: SNA02-48
intramuscular injection
BIOLOGICAL: Placebo
intramuscular injection
BIOLOGICAL: HTIG
intr...